Measles Outbreak Cases Cross 100 Mark In US, Australia Sees Sudden Surge Of The Infectious Disease

Updated Feb 23, 2025 | 11:46 AM IST

SummaryMeasles continues to create havoc with over 100 people infected in US. New health guidelines and advisories are being issued to ensure people remain safe and vigilant.
(Credit-Canva)

(Credit-Canva)

The current measles outbreak has gripped US states like Texas and New Mexico leaving people worried whether it would become a new pandemic. According to the Texas Department of State Health Services as of February 21, 90 cases were diagnosed in the last month in the South Plains area, with at least 77 of them were reported in children and teens under 17.

Measles is highly contagious and can be deadly. The outbreak, which started spreading in late January, has resulted in multiple hospitalizations, with at least nine confirmed cases and three probable cases as of early February. Health officials caution that at least one in five infected individuals will have to be hospitalized, highlighting the severity of the situation.

Misinformation surrounding vaccines and with the new Trump administration anti-vaccine campaigs, has causing parents to hesitate or refuse vaccination.

Furthermore, the country down under Australia is also witnessing a surge in measles cases as health officials in Sydney have issued an urgent alert, urging residents to watch for measles symptoms after an infected individual visited several places in Sydney over the last seven days.

Authorities report that the traveller had returned from South East Asia where there are ongoing outbreaks of measles.

What Are The Symptoms Measles?

Key symptoms of measles include fever, a runny nose, sore eyes, and a cough. Typically, a red, blotchy rash appears three to four days later, spreading from the head down to the body. Symptoms can manifest between 7 and 18 days after exposure.

Anyone who experiences these symptoms after potential exposure should immediately contact their doctor or emergency department. It is crucial to call ahead before visiting to avoid potentially exposing others in the waiting room. Dr. Selvey also highlighted that ongoing measles outbreaks are occurring in various parts of the world, making awareness and prompt action essential.

Why It Is Important To Get Vaccinated?

According to CDC everyone should get the MMR vaccine. It protects you from measles, mumps, and rubella. Getting vaccinated helps stop these diseases from spreading. There are two safe MMR vaccines available. They work the same way, so it doesn't matter which one you get. Kids can also get a shot that protects against chickenpox too, but this is only for children.

Who Should Get Vaccinated?

Kids Need Two Shots

All children should get two MMR shots. The first shot should be given when they are between 12 and 15 months old. The second shot should be given when they are between 4 and 6 years old. If needed, the second shot can be given earlier, but it must be at least 28 days after the first shot.

College Students Need to Be Protected

Students going to college or other schools after high school, need two shots if they are not already immune. The shots must be at least 28 days apart.

Adults Need at Least One Shot

Most adults need at least one MMR shot. Some adults need two shots, especially those who work in healthcare, travel a lot, or go to college. These people should get two shots, with 28 days between them.

Travelers Need to Be Extra Careful

Anyone traveling to other countries should make sure they are protected. Babies 6 to 11 months old should get one shot before traveling. Kids 12 months and older, teens, and adults need two shots, with 28 days between them.

Healthcare Workers Must Be Immune

People who work in healthcare should have proof that they are immune to measles, mumps, and rubella. If they are not immune, they need two MMR shots, spaced 28 days apart.

Women Thinking About Having Babies

Women who might get pregnant should talk to their doctor about the MMR vaccine. It's safe to get the shot while breastfeeding.

End of Article

Bruce Willis Health Update: His Death News Is A Hoax; 'He's Still Alive And Well'

Updated Mar 9, 2026 | 06:48 AM IST

SummaryActor Bruce Willis is alive after a viral death hoax spread online. His representatives dismissed the claim, confirming he remains at home with family while living with frontotemporal dementia, diagnosed after earlier aphasia in 2022.
Bruce Willis Health Update: His Death News Is A Hoax; 'He's Still Alive And Well'

Credits: Wikimedia Commons

Bruce Willis is alive. Last week, a death hoax of Bruce Willis have circulated, however, his representatives confirmed on March 7, Saturday that the news is fabricated. "He joins the long list of celebrities who have been victimized by this hoax. He's still alive and well, stop believing what you see on the Internet," his official representative stated. In fact, in the coming 19th of the month, The Die Hard star will turn 71. Bruce Willis is currently at his home with his family and is living with frontotemporal dementia. He is continuing into third year living with the condition.

Bruce Willis Health Update: Time Line Of Diagnosis

In March 2022, fans were shocked by a family statement revealing Willis had been diagnosed with aphasia. The announcement was brief but clear: the condition was affecting his cognitive abilities and making it impossible for him to continue his acting career. However, aphasia was just one piece of the puzzle.

By February 2023, a more specific diagnosis emerged. The Willis family confirmed Bruce was dealing with frontotemporal dementia, a degenerative condition that often begins with language difficulties and eventually affects decision-making, emotional regulation, and behavior.

Read: Bruce Willis Health Update: A Diagnostic Timeline From Aphasia To Dementia

"Challenges with communication are just one symptom of the disease Bruce faces," the family shared at the time, emphasizing that the condition affects far more than speech.

Unlike Alzheimer’s disease, FTD tends to strike earlier, often in one’s 50s or 60s—and can progress quickly. It affects the frontal and temporal lobes of the brain, areas associated with language, behavior, and executive function. Currently, there is no cure.

Read: Bruce Willis’ Wife Emma Says He Is Unaware of His Dementia Diagnosis

What Is Frontotemporal Dementia?

Frontotemporal dementia is a less prevalent type of dementia that mainly occurs in the frontal and temporal lobes of the brain. It tends to affect behavior, personality, language, and movement more than memory, particularly in its initial stages.

In contrast to Alzheimer's, which generally strikes older individuals, FTD can hit at an earlier age—sometimes as young as 40. The symptoms can range from changes in personality, emotional flatness, or the inability to show empathy to impulsiveness, so it is especially hard for spouses and children to cope.

Emma's case illustrates how abrupt and disrupting this diagnosis can be—not only for the patient but for caregivers as well.

Whereas Bruce Willis' diagnosis hit global headlines, the mental toll taken by Emma, his caregiver, was largely in the background—until she decided to come forward.

Caregiving is a respectable position, but it's also a challenging and thankless one. For those who are caring for loved ones with dementia or other chronic illnesses, the stress of "keeping it all together" can result in a condition called caregiver burnout.

"Caring for someone is the most intimate and demanding work of love," Emma explained, "but when you're not noticed or supported, it begins to undermine your health—mentally and physically."

End of Article

Meghalaya On High Alert After Two Meningococcal Cases at Army Training Centre

Updated Mar 8, 2026 | 12:22 PM IST

SummaryMeghalaya health officials have asked locals to avoid crowded places after two Agniveer trainees have died of suspected meningococcal bacterial infection at a training centre in Shillong in February. The remaining 28 trainees have been placed in quarantine
Meghalaya On High Alert After Two Meningococcal Cases at Army Training Centre

Credit: Canva

Meghalaya health officials have asked locals to avoid crowded places after two Agniveer trainees have died of suspected meningococcal bacterial infection at a training centre in Shillong in February.

While the first trainee died at the Military Hospital in the Assam Regimental Centre (ARC), the other died on February 23. The remaining 28 trainees have been placed in quarantine.

Joram Beda, Health and Family Welfare Commissioner-Secretary, said the East Khasi Hills District Surveillance Unit has initiated an active epidemiological investigation, including contact tracing, isolation of close contacts, and fumigation, which has been carried out in and around the affected military facility.

“Case investigation, contact tracing, laboratory review, and surveillance strengthening measures are currently underway,” the official advisory read.

The Health and Family Welfare Department also said the State Surveillance Unit has been activated and a detailed epidemiological investigation is currently underway. Authorities further added that surveillance has been strengthened not just within the Army training establishment but also in surrounding areas as a precaution.

The state government has asked people to avoid crowded areas, wear masks in crowded places, practise good respiratory hygiene and wash their hands regularly with soap and sanitiser.

It also asked residents to report to the nearest medical facility in cases of sudden high fever, headache, vomiting, rapidly spreading purpuric (purple-coloured spots or patches) rashes, pale limbs at a later stage, and circulatory collapse, shock, and multi-organ failure.

What Is Meningococcal Disease?

Meningococcal disease is a severe, life-threatening bacterial infection caused by Neisseria meningitidis, leading to meningitis (brain/spinal cord lining infection, also known as IMD) or septicemia (bloodstream infection)

How Does Meningococcal Disease Spread?

Meningococcal bacteria are transmitted through respiratory droplets, by coughing, sneezing, kissing, or sharing food and drinks. The greatest risk occurs between people with extended, close contact, such as family members and sexual partners. Prolonged riding in enclosed vehicles, such as buses, planes, with the infected person, also greatly increases risk.

CDC states that infants below one year, adolescents 16–23 years old, immunocompromised patients, and residents of communal environments are at greatest risk.

Early Symptoms of Meningococcal Disease

The infection at first presents a nonspecific viral illness, but can worsen suddenly. Adults must be aware of the following signs:

  • Fever, headache, stiff neck – classic symptoms of meningitis
  • Red spots or rash – typically seen as pinpricks or larger bruise-like patches, a sign of blood vessel involvement
  • Nausea, vomiting, photophobia (light sensitivity)
  • Confusion, lethargy, rapid breathing, seizures – signs of severe progression
  • Neck stiffness and changed mental status, usually with fever

In the most severe cases, sepsis, exhaustion, coldness of extremities, and coma may ensue, all necessitating immediate medical intervention. Shockingly, worsening can happen within 12 hours of the onset of symptoms.

Diagnosis and Treatment of Meningococcal Disease

The gold-standard diagnosis for invasive meningococcal disease involves a combination of blood cultures and cerebrospinal fluid (CSF) analysis obtained through lumbar puncture.

However, in cases where increased intracranial pressure is suspected, performing a lumbar puncture may need to be delayed to avoid complications. Additionally, polymerase chain reaction (PCR) testing plays a crucial role in rapidly identifying the infection, particularly when prior antibiotic treatment may interfere with traditional culture results.

IMD survivors develop severe complications: hearing loss, neurological injury, kidney failure, or limb amputation by necrosis. Unfortunately, natural infection does not offer absolute lifelong immunity; recurrence, although infrequent, can occur, warranting immune deficiency assessments.

Vaccination is the best protection. Vaccines protect against several serogroups (A, B, C, W, Y, X) and are universally advised, particularly among adolescents, travelers, and those at risk.

End of Article

Novo Nordisk And Hims & Hers Health End Dispute, Plan to Sell Wegovy Together

Updated Mar 7, 2026 | 12:30 PM IST

SummaryMarket analysts have expressed surprise at the move, as ​both Novo and Hims have been previously engaged in legal battle over Wegovy's active ingredient Semaglutide -- popularly known for weight loss, but also effective for diabetes.
Novo Nordisk And Hims & Hers Health End Dispute, Plan to Sell Wegovy Together

Credit: iStock

Wegovy maker Novo Nordisk has ended its legal dispute with the Hims & Hers Health platform, according to a media report.

The two companies are likely to partner and sell the blockbuster obesity drug Wegovy together on the Hims & Hers Health platform, Bloomberg News reported.

Market analysts have expressed surprise on the move, as both Novo and Hims have been previously engaged in legal battle over Wegovy.

“There is no other way to describe the Hims news as both a surprise and an unabashed positive for Hims' stock,” Leerink Partners analyst Michael Cherny was quoted as saying in a note to clients.

A Novo spokesperson said in an emailed statement that the company is "always in conversation with companies that can help improve patient access to FDA-approved medicines".

The Dispute Between Novo and Hims

In February, Novo sued Hims for launching a similar version of its new Wegovy weight-loss pill for $49.

The Danish drugmaker accused Hims of patent infringement on Semaglutide -- the active ingredient behind its best-selling medications Ozempic and Wegovy.

Semaglutide is popularly known for weight loss , but is also effective for diabetes and is used primarily for that.

The US Food and Drug Administration (FDA) had also threatened action against Hims.

Last year, Novo had to end a short-lived agreement to sell Wegovy over Him's marketing tactics and continued sales of copycat versions of Wegovy.

Recently, the FDA has signaled plans to crack down on the proliferation of copycat, or compounded, weight-loss drugs.

Wegovy And Ozempic To Cost Less In 2027

Currently, Wegovy injections and pills cost $1,349.02 a month, whereas Ozempic and Rybelus cost $1,027.51, Novo told PEOPLE.

Individuals with commercial insurance pay $25 a month, whereas those using cash pay between $149 to $499. Patients on Medicare will pay $274 per month.

Late in February, Novo Nordisk announced it would slash the price for all doses:

  • The list price of Wegovy injections and the new Wegovy pill will be cut in half
  • Ozempic injections will be cut by 35 percent
  • The semaglutide tablet Rybelsus will now cost $675 a month
Rybelsus has been approved by the US Food and Drug Administration (FDA) to reduce the risk of heart attacks in those with diabetes.

"There are more than 100 million people living with obesity and over 35 million with type 2 diabetes and, and for some, list price has been a real barrier to access and affordability," Jamey Millar, Executive Vice President, US Operations of Novo Nordisk Inc., was quoted as saying to PEOPLE.

Indian Drugmakers Rush For Generic Weight Loss Drugs

Meanwhile, amid the patent expiration of semaglutide, several pharma companies in India are planning big launches of Wegovy's generic versions.

Several leading drugmakers have already secured regulatory approval or recommendations to produce and market generic versions of the weight loss drugs in the country.

Hyderabad-based Dr. Reddy's already applied for a trademark with the brand name Obeda and a logo.

Other companies like Sun Pharma, Zydus Lifesciences, and Nacto Pharma are also entering the rat race of launching multiple generic versions to make the treatment more affordable for patients with obesity and weight-related health risks.

Sun Pharma also announced the plans for "day-one" launches of generic prefilled pens.

End of Article